0000899243-18-018107.txt : 20180626 0000899243-18-018107.hdr.sgml : 20180626 20180626142758 ACCESSION NUMBER: 0000899243-18-018107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180622 FILED AS OF DATE: 20180626 DATE AS OF CHANGE: 20180626 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GOLD DANIEL P PHD CENTRAL INDEX KEY: 0001288233 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50484 FILM NUMBER: 18919062 MAIL ADDRESS: STREET 1: 10445 PACIFIC CENTER CT CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MEI Pharma, Inc. CENTRAL INDEX KEY: 0001262104 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 510407811 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 3611 VALLEY CENTER DRIVE STREET 2: SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92130 BUSINESS PHONE: 858-792-6300 MAIL ADDRESS: STREET 1: 3611 VALLEY CENTER DRIVE STREET 2: SUITE 500 CITY: SAN DIEGO STATE: CA ZIP: 92130 FORMER COMPANY: FORMER CONFORMED NAME: MARSHALL EDWARDS INC DATE OF NAME CHANGE: 20030902 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-22 0 0001262104 MEI Pharma, Inc. MEIP 0001288233 GOLD DANIEL P PHD C/O MEI PHARMA, INC. 3611 VALLEY CENTRE DRIVE, SUITE 500 SAN DIEGO CA 92130 1 1 0 0 Chief Executive Officer Stock Option (Right to Buy) 4.33 2018-06-22 4 A 0 380000 0.00 A 2028-06-22 Common Stock 380000 380000 D One-quarter of such Options shall vest on June 22, 2019 and the remaining three-quarters of such options shall vest monthly over a three-year period beginning on June 22, 2019. /s/ Brian G. Drazba, as attorney in fact 2018-06-26